Position in CDNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,433
+$10,038 QoQ
Shares Held
601
+2761.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MAI Capital Management holds $75,211,966 across 16 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
71,216 | $35,704,853 | |
| 2 | LH |
Labcorp Holdings Inc.
|
35,684 | $9,991,520 | |
| 3 | DHR |
Danaher Corp /De/
|
42,750 | $8,143,019 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
32,244 | $6,230,184 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
1,721 | $2,198,594 | |
| 6 | RVTY |
Revvity, Inc.
|
18,480 | $2,056,084 | |
| 7 | WAT |
Waters Corp /De/
|
5,287 | $1,982,836 | |
| 8 | A |
Agilent Technologies, Inc.
|
14,111 | $1,874,363 |
All Filings in CDNA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,433 | 601 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $395 | 21 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||